Clinical Trials Logo

Clinical Trial Summary

This is a prospective, open-label, 1-arm, multicenter observational study to determine the dose and time interval of Remicade (Infliximab) infusions in psoriatic arthritis (PsA).


Clinical Trial Description

This study population was chosen from a non-probability sample. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00725296
Study type Observational
Source Merck Sharp & Dohme Corp.
Contact
Status Completed
Phase N/A
Start date December 2004
Completion date July 2010

See also
  Status Clinical Trial Phase
Completed NCT02181673 - A Study of Golimumab in Participants With Active Psoriatic Arthritis Phase 3
Recruiting NCT04936308 - Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent Phase 3
Terminated NCT00090129 - Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis Phase 3
Withdrawn NCT03625089 - Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis N/A
Recruiting NCT05571696 - Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases N/A
Active, not recruiting NCT05071664 - A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis Phase 2
Completed NCT00938015 - Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis N/A
Suspended NCT03703934 - Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy Controls
Recruiting NCT05092269 - A Long-term Extension Study of Ustekinumab in Pediatric Participants Phase 3
Terminated NCT05083078 - A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis Phase 1
Completed NCT02436785 - Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? N/A
Completed NCT02294227 - 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis Phase 3
Completed NCT00998829 - Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis N/A
Completed NCT00760669 - An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants Phase 4
Completed NCT00367237 - Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422) Phase 3
Completed NCT00051623 - A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis Phase 3
Withdrawn NCT04680676 - A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis Phase 2
Completed NCT03008590 - Low Dose Naltrexone for Chronic Pain From Arthritis Phase 2
Recruiting NCT05657847 - Novel Complex Radiodiagnostics of Peripherial Arthropathies
Completed NCT02875184 - A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands